Laboratory of Addiction Genetics Makes Important Discovery in Methamphetamine Addiction
EurekAlert.org reported that researchers in the Laboratory of Addiction Genetics in the Department of Pharmacology & Experimental Therapeutics and Psychiatry at Boston University School of Medicine have identified a gene that may be linked to methamphetamine addiction. The article, “Hnrnph1 is a Quantative Trait Gene for Methamphetamine Sensitivity”Hnrnph1 is a Quantative Trait Gene for Methamphetamine Sensitivity” in PLOS Genetics. The article’s first author, Neema Yazdani, a Program in Biomolecular Pharmacology Ph.D. graduate student, is currently conducting his doctoral research work in the Laboratory of Addiction Genetics under the mentorship of Laboratory Director and Principal Investigator, Camron D. Bryant, Ph.D., who is the senior and corresponding author on the paper. Dr. Bryant’s research focuses on the genetic basis of behaviorial and molecular traits in substance abuse with the goal of discovering novel psychotherapeutics to treat addictive disorders. For more on this research, please visit the Laboratory of Addiction Genetics website.